Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The goblet cell secretion machinery is a coordinated system of proteins and signaling molecules that regulate the exocytosis of mucins, primarily MUC5AC and MUC5B, from specialized epithelial cells. This machinery is essential for maintaining the protective mucus barrier on mucosal surfaces, including the lungs, gut, and eyes (Davis et al., 2004). Key molecular components include the Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) protein, which facilitates the movement of mucin granules to the cell surface, and the SNARE complex (comprising VAMP8, SNAP23, and Syntaxin 3), which mediates the fusion of granule membranes with the plasma membrane (Ren et al., 2015). In diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, the machinery is overactive, leading to mucus hypersecretion and airway obstruction (Fahy and Dickey, 2010). Conversely, in dry eye syndrome, enhancing this machinery's activity is a therapeutic goal. Drugs like BIO-11006 target the MARCKS protein to inhibit hypersecretion, while secretagogues like Diquafosol act on P2Y2 receptors to stimulate the machinery in ocular tissues (Green et al., 2011).
Inhibition of MARCKS protein phosphorylation to prevent granule translocation; cleavage of SNARE proteins to prevent membrane fusion; activation of P2Y2 receptors to stimulate calcium-dependent exocytosis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Goblet cell secretion machinery.